pyrantel - CISMeF

Preferred Label : pyrantel;

MeSH definition : A depolarizing neuromuscular-blocking agent, that causes persistent nicotinic activation resulting in spastic paralysis of susceptible nematodes. It is a drug of second-choice after benzimidazoles for treatment of ascariasis, hookworm, and pinworm infections, being effective after a single dose. (From Smith and Reynard, Textbook of Pharmacology, 1992, p920);

MeSH CAS label : pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)-, (E)-;

MeSH Related Number : 15686-83-6 (Pyrantel);

Registry Number MeSH : 15686-83-6;

MeSH annotation : an antinematodal agent;

Wikipedia link : https://en.wikipedia.org/wiki/Pyrantel;

Codes EINECS : 239-774-1;

Is substance : O;

UNII : 4QIH0N49E7;

InChIKey : YSAUAVHXTIETRK-AATRIKPKSA-N;

Details

Origin ID

D011715;

UMLS CUI

C0034235;

ATC code(s)
- pyrantel [ATC Code]
- tetrahydropyrimidine derivatives [ATC Code]
ATC code(s)
- pyrantel [ATC Code]
- tetrahydropyrimidine derivatives [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- pyrantel [Substance BNPC]
Currated CISMeF NLP mapping
- Product containing pyrantel (medicinal product) [SNOMED CT concept]
- Pyrantel [ICD-11 Extension code]
- Pyrantel [ICHI extension code]
- Pyrantel [SMS substance]
- Pyrantel [NCIt concept]
- Pyrantel (substance) [SNOMED CT concept]
- pyrantel [SNOMED Notion]
Pharmacological action(s)
- antinematodal agents [MeSH Descriptor]
- neuromuscular agents [MeSH Descriptor]
- neuromuscular depolarizing agents [MeSH Descriptor]
Record concept(s)
- pyrantel [MeSH concept]
Related MeSH Supplementary Concept(s)
- oxantel [MeSH Supplementary Concept]
- pyrantel citrate [MeSH Supplementary Concept]
- quantrel [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing pyrantel (medicinal product) [SNOMED CT concept]
- Pyrantel [ICD-11 Extension code]
- Pyrantel [NCIt concept]
- Pyrantel (substance) [SNOMED CT concept]
- pyrantel [ATC Code]
- pyrantel [Substance BNPC]
- pyrantel [SNOMED Notion]
Validated automatic mappings to BTNT
- pyrantel [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients